Overview
At LuminaTech Solutions, we are revolutionizing the biotech landscape by leveraging advanced technologies to develop personalized medicine solutions. Our mission is to tailor medical treatments to individual genetic profiles, enhancing the efficacy and safety of therapies. Since our inception in 2024, we have made significant strides in developing our proprietary platform, which integrates genetic analysis with treatment algorithms. Currently, we have successfully validated our technology in a series of preliminary studies, proving its potential to improve patient outcomes and reduce healthcare costs. However, to accelerate our growth and fully realize our vision, we are seeking an investment of $145,000. This capital will primarily fund our ongoing research and development efforts, enabling us to refine our platform further and conduct larger clinical trials. With the rapid evolution of the biotech industry and increasing demand for personalized healthcare solutions, we believe this is the perfect time to elevate our operations. We have already established strategic partnerships with leading research institutions and healthcare providers, which will facilitate the adoption of our…
Use of funds
The $145,000 will be allocated as follows:
- R&D Expansion (50%): Enhance our research capabilities, including hiring additional scientists and purchasing advanced laboratory equipment.
- Clinical Trials (30%): Fund the next phase of clinical trials to validate our platform in real-world settings.
- Marketing Initiatives (20%): Develop marketing materials and outreach strategies to secure partnerships and early adopters.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.